Table 4.
Studies
|
Selection
|
Comparability
|
Outcome
|
Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|
First author | Year | A | B | C | D | E | F | G | H | score |
Kjellman et al1 | 2003 | * | * | * | * | * | * | 6 | ||
Feng and Wang62 | 2015 | * | * | * | * | * | * | 6 | ||
Ito et al12 | 2010 | * | * | * | * | * | * | 6 | ||
Jovanovic et al32 | 2015 | * | * | * | * | * | * | 6 | ||
Gnemmi et al14 | 2014 | * | * | * | * | * | * | * | 7 | |
Miyauchi et al22 | 2013 | * | * | * | * | * | 5 | |||
Chen et al20 | 2011 | * | * | * | * | * | * | 6 | ||
Wang et al33 | 1996 | * | * | * | * | * | * | 6 | ||
Tisell et al26 | 2003 | * | * | * | * | * | * | 6 |
Notes: A: representative of the exposed cohort; B: selection of the nonexposed cohort; C: ascertainment of exposure; D: demonstration that outcome of interest was not present at the start of study; E: comparability of cohorts on the basis of the design or analysis; F: assessment of outcome; G: adequacy of follow-up for outcomes to occur (≥2 years or outcomes occurred in all patients); H: adequacy of follow-up of cohorts (follow-up rate ≥75%).
Abbreviation: NOS, Newcastle–Ottawa scale.